Alto Neuroscience (ANRO) Current Assets (2023 - 2026)

Alto Neuroscience (ANRO) has 4 years of Current Assets data on file, last reported at $269.1 million in Q1 2026.

• For the quarter ending Q1 2026, Current Assets rose 64.58% year-over-year to $269.1 million; the trailing twelve-month figure through Mar 2026 stood at $269.1 million (up 64.58% YoY), and the FY2025 full-year result was $177.7 million, up 4.95% from the prior year.
• Current Assets improved to $269.1 million in Q1 2026, from $177.7 million in the prior quarter.
• In the past five years, Current Assets ranged from a high of $269.1 million in Q1 2026 to a low of $85.4 million in Q4 2023.
• A 4-year average of $174.2 million and a median of $173.5 million in 2024 frame the typical range for Current Assets.
• Across the five-year window, Current Assets surged 98.31% in 2024 and fell 24.02% in 2025, its largest moves.
• Tracing ANRO's Current Assets over 4 years: stood at $85.4 million in 2023, then surged by 98.31% to $169.3 million in 2024, then advanced by 4.95% to $177.7 million in 2025, then jumped by 51.43% to $269.1 million in 2026.
• Business Quant data shows ANRO's Current Assets at $269.1 million in Q1 2026, $177.7 million in Q4 2025, and $139.4 million in Q3 2025.